Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Remimazolam Tosilate Sedation Compared With Midazolam Sedation in Dental Patients: A Double Blind, Prospective , Randomized Controlled Trial

NCT04602845 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04602845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Remimazolam Tosilate Sedation Compared With Midazolam Sedation in Dental Patients: A Double Blind, Prospective , Randomized Controlled Trial
Lead sponsor
Peking University
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2021
Completion date
December 31, 2021
Enrollment
81 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

midazolam, remimazolam, sedation complication